ID: PMRREP3640
Format: PPT*, PDF, EXCEL
Last Updated: 20 June 2022
Industry: Healthcare
Number of Pages: 249
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation
4. Key Success Factors
4.1. Pipeline Analysis
4.2. Recent Product Launches
4.3. Promotional Strategies, by Manufacturers
4.4. Regulatory Scenario
5. Global Meningococcal Vaccine Market Demand (in Value or Size in US$ Mn) Analysis 2013-2021 and Forecast, 2022-2028
5.1. Historical Market Value (US$ Mn) Analysis, 2013-2021
5.2. Current and Future Market Value (US$ Mn) Projections, 2022-2028
5.2.1. Y-o-Y Growth Trend Analysis
5.2.2. Absolute $ Opportunity Analysis
6. Market Background
6.1. Macro-Economic Factors
6.1.1. Global Healthcare Spending Outlook
6.1.2. Global Pharmaceutical Outlook
6.1.3. Regional Healthcare Market Outlook
6.2. Forecast Factors - Relevance & Impact
6.3. Value Chain
6.4. Pipeline Analysis
6.5. Market Dynamics
6.5.1. Drivers
6.5.2. Restraints
6.5.3. Opportunity Analysis
7. Global Meningococcal Vaccine Market Analysis 2013-2021 and Forecast 2022-2028, by Product Type
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2013 - 2021
7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2022 - 2028
7.3.1. Meningococcal Polysaccharide Vaccine (MPSV4)
7.3.2. Meningococcal Conjugate Vaccine (MCV4)
7.3.3. Serogroup B Meningococcal Vaccine (MenB-FHpb/MenB-4C)
7.4. Market Attractiveness Analysis By Product Type
8. Global Meningococcal Vaccine Market Analysis 2013-2021 and Forecast 2022-2028, by Age Group
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Age Group, 2013 - 2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Age Group, 2022 - 2028
8.3.1. Infants (0-24 months)
8.3.2. Children
8.3.3. Adolescents and Young Adults
8.3.4. Adults
8.4. Market Attractiveness Analysis By Age Group
9. Global Meningococcal Vaccine Market Analysis 2013-2021 and Forecast 2022-2028, by Distribution Channel
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013 - 2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2022 - 2028
9.3.1. Institutional Sales
9.3.1.1. Hospitals
9.3.1.2. Community Clinics
9.3.1.3. Public Health Agencies
9.3.2. Retail Sales
9.3.2.1. Retail Pharmacy
9.3.2.2. Mail Order Pharmacy
9.4. Market Attractiveness Analysis By Distribution Channel
10. Global Meningococcal Vaccine Market Analysis 2013-2021 and Forecast 2022-2028, by Region
10.1. Introduction
10.2. Historical Market Size (US$ Mn) and Volume Analysis By Region, 2013 - 2021
10.3. Current Market Size (US$ Mn) and Volume Analysis and Forecast By Region, 2022 - 2028
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. East Asia
10.3.5. South Asia
10.3.6. Oceania
10.3.7. Middle East and Africa (MEA)
10.4. Market Attractiveness Analysis By Region
11. North America Meningococcal Vaccine Market Analysis 2013-2021 and Forecast 2022-2028
11.1. Introduction
11.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 - 2021
11.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2028
11.3.1. By Country
11.3.1.1. U.S.
11.3.1.2. Canada
11.3.2. By Product Type
11.3.3. By Age Group
11.3.4. By Distribution Channel
11.4. Market Attractiveness Analysis
11.5. Market Trends
11.6. Key Market Participants - Intensity Mapping
11.7. Drivers and Restraints - Impact Analysis
12. Latin America Meningococcal Vaccine Market Analysis 2013-2021 and Forecast 2022-2028
12.1. Introduction
12.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 - 2021
12.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2028
12.3.1. By Country
12.3.1.1. Brazil
12.3.1.2. Mexico
12.3.1.3. Rest of Latin America
12.3.2. By Product Type
12.3.3. By Age Group
12.3.4. By Distribution Channel
12.4. Market Attractiveness Analysis
12.5. Market Trends
12.6. Key Market Participants - Intensity Mapping
12.7. Drivers and Restraints - Impact Analysis
13. Europe Meningococcal Vaccine Market Analysis 2013-2021 and Forecast 2022-2028
13.1. Introduction
13.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 - 2021
13.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2028
13.3.1. By Country
13.3.1.1. Germany
13.3.1.2. Italy
13.3.1.3. France
13.3.1.4. U.K.
13.3.1.5. Spain
13.3.1.6. BENELUX
13.3.1.7. Russia
13.3.1.8. Rest of Europe
13.3.2. By Product Type
13.3.3. By Age Group
13.3.4. By Distribution Channel
13.4. Market Attractiveness Analysis
13.5. Market Trends
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
14. South Asia Meningococcal Vaccine Market Analysis 2013-2021 and Forecast 2022-2028
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 - 2021
14.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2028
14.4.1. By Country
14.4.1.1. India
14.4.1.2. Thailand
14.4.1.3. Indonesia
14.4.1.4. Malaysia
14.4.1.5. Rest of South Asia
14.4.2. By Product Type
14.4.3. By Age Group
14.4.4. By Distribution Channel
14.5. Market Attractiveness Analysis
14.6. Market Trends
14.7. Key Market Participants - Intensity Mapping
14.8. Drivers and Restraints - Impact Analysis
15. East Asia Meningococcal Vaccine Market Analysis 2013-2021 and Forecast 2022-2028
15.1. Introduction
15.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 - 2021
15.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2028
15.3.1. By Country
15.3.1.1. China
15.3.1.2. Japan
15.3.1.3. South Korea
15.3.2. By Product Type
15.3.3. By Age Group
15.3.4. By Distribution Channel
15.4. Market Attractiveness Analysis
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
16. Oceania Meningococcal Vaccine Market Analysis 2013-2021 and Forecast 2022-2028
16.1. Introduction
16.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 - 2021
16.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2028
16.3.1. By Country
16.3.1.1. Australia
16.3.1.2. New Zealand
16.3.2. By Product Type
16.3.3. By Age Group
16.3.4. By Distribution Channel
16.4. Market Attractiveness Analysis
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
17. Middle East and Africa Meningococcal Vaccine Market Analysis 2013-2021 and Forecast 2022-2028
17.1. Introduction
17.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 - 2021
17.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2028
17.3.1. By Country
17.3.1.1. GCC Countries
17.3.1.2. Turkey
17.3.1.3. Northern Africa
17.3.1.4. South Africa
17.3.1.5. Rest of Middle East and Africa
17.3.2. By Product Type
17.3.3. By Age Group
17.3.4. By Distribution Channel
17.4. Market Attractiveness Analysis
17.5. Market Trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
18. Emerging Countries Meningococcal Vaccine Market Analysis 2013-2021 and Forecast 2022-2028
18.1. Introduction
18.1.1. Market Value Proportion Analysis, By Key Countries
18.1.2. Global Vs. Country Growth Comparison
18.2. China Meningococcal Vaccine Market Analysis
18.2.1. Introduction
18.2.2. PEST Analysis
18.2.3. Market Value Proportion Analysis by Market Taxonomy
18.2.4. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy
18.2.4.1. By Product Type
18.2.4.2. By Age Group
18.2.4.3. By Distribution Channel
18.3. India Meningococcal Vaccine Market Analysis
18.3.1. Introduction
18.3.2. PEST Analysis
18.3.3. Market Value Proportion Analysis by Market Taxonomy
18.3.4. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy
18.3.4.1. By Product Type
18.3.4.2. By Age Group
18.3.4.3. By Distribution Channel
18.4. Brazil Meningococcal Vaccine Market Analysis
18.4.1. Introduction
18.4.2. PEST Analysis
18.4.3. Market Value Proportion Analysis by Market Taxonomy
18.4.4. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy
18.4.4.1. By Product Type
18.4.4.2. By Age Group
18.4.4.3. By Distribution Channel
19. Market Structure Analysis
19.1. Market Analysis by Tier of Companies (Meningococcal Vaccine)
19.2. Market Share Analysis of Top Players
19.3. Brand Share Analysis
19.4. Market Presence Analysis
19.4.1. By Regional footprint of Players
19.4.2. Product foot print by Players
19.4.3. Channel Foot Print by Players
20. Competition Analysis
20.1. Competition Dashboard
20.2. Pricing Analysis by Competition
20.3. Competition Benchmarking
20.4. Competition Deep Dive
20.4.1. Sanofi Pasteur Inc.
20.4.1.1. Overview
20.4.1.2. Product Portfolio
20.4.1.3. Profitability by Market Segments (Product/Channel/Region)
20.4.1.4. Sales Footprint
20.4.1.5. Strategy Overview
20.4.1.5.1. Marketing Strategy
20.4.1.5.2. Product Strategy
20.4.1.5.3. Channel Strategy
20.4.2. GlaxoSmithKline
20.4.2.1. Overview
20.4.2.2. Product Portfolio
20.4.2.3. Profitability by Market Segments (Product/Channel/Region)
20.4.2.4. Sales Footprint
20.4.2.5. Strategy Overview
20.4.2.5.1. Marketing Strategy
20.4.2.5.2. Product Strategy
20.4.2.5.3. Channel Strategy
20.4.3. Wyeth Pharmaceuticals
20.4.3.1. Overview
20.4.3.2. Product Portfolio
20.4.3.3. Profitability by Market Segments (Product/Channel/Region)
20.4.3.4. Sales Footprint
20.4.3.5. Strategy Overview
20.4.3.5.1. Marketing Strategy
20.4.3.5.2. Product Strategy
20.4.3.5.3. Channel Strategy
21. Assumptions and Acronyms Used
22. Research Methodology
